
ヘルスとヘルスケア
人工智能如何推动生命科学领域从“重磅药物”转向持续研发
数十年来,生命科学创新一直遵循着一种熟悉的模式:识别有前景的分子,通过线性研发管道推进,最终将其推向市场。从降低心血管疾病死亡率的他汀类药物,到治愈丙型肝炎的疗法,这一模式带来了许多令人瞩目的重磅药物突破。
数十年来,生命科学创新一直遵循着一种熟悉的模式:识别有前景的分子,通过线性研发管道推进,最终将其推向市场。从降低心血管疾病死亡率的他汀类药物,到治愈丙型肝炎的疗法,这一模式带来了许多令人瞩目的重磅药物突破。
For decades, life sciences innovation has followed a familiar model: Identify a promising molecule, advance it through a linear pipeline and bring it to market. This approach has delivere...
The journey from drug discovery to patient access is complex, costly and time-consuming. While generative AI (genAI) is transforming preclinical drug discovery, similar disruptions are ne...

